Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02309-1
- By:
- Publication type:
- Article
Works by Qiu, Mo‐Qin
Results: 4
1
2
Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child–Pugh grade B patients with locally advanced hepatocellular carcinoma.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-023-02232-5
- By:
- Publication type:
- Article
3
Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2545, doi. 10.1002/cam4.2068
- By:
- Publication type:
- Article
4
Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02596-0
- By:
- Publication type:
- Article